Age-related changes in AMP-activated protein kinase after stroke

Age

Volumn 34, Issue 1, 2012, Pages 157-168

  Liu, Fudong ^a   Benashski, Sharon E ^a   Persky, Rebecca ^a   Xu, Yan ^a   Li, Jun ^a   McCullough, Louise D ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

Aging; AMPK; Compound C; Hypothermia; Ischemic stroke; Middle cerebral artery occlusion (MCAO)

Indexed keywords

[[4 (2 PIPERIDIN 1 YL ETHOXY)PHENYL]] 3 PYRIDIN 4 YL PYRRAZOL[1,5 A]PYRIMIDINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE INHIBITOR; PLACEBO; PROTEIN SERINE THREONINE KINASE INHIBITOR; UNCLASSIFIED DRUG; BIOLOGICAL MARKER;

ABNORMAL BEHAVIOR; AGING; ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INFARCTION SIZE; BRAIN LEVEL; BRAIN SIZE; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DRUG RESPONSE; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; EXPERIMENTAL MOUSE; INDUCED HYPOTHERMIA; MORTALITY; MOUSE; NEUROPROTECTION; NONHUMAN; ANIMAL; BRAIN; COMPARATIVE STUDY; DISEASE MODEL; ENZYMOLOGY; MALE; METABOLISM; PREDICTIVE VALUE; SENSITIVITY AND SPECIFICITY; STROKE;

AGING; AMP-ACTIVATED PROTEIN KINASES; ANIMALS; BIOLOGICAL MARKERS; BRAIN; DISEASE MODELS, ANIMAL; MALE; MICE; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY; STROKE;

EID: 84862312209     PISSN: 01619152     EISSN: 15744647     Source Type: Journal    
DOI: 10.1007/s11357-011-9214-8     Document Type: Article

References (54)

1. Abete P, Cacciatore F, Testa G, Della-Morte D, Galizia G, de Santis D, Calabrese C, Cioppa A, Ferrara N, Rengo F (2010) Ischemic preconditioning in the aging heart: from bench to bedside. Ageing Res Rev 9:153-162
2. Alexis NE, Back T, Zhao W, Dietrich WD, Watson BD, Ginsberg MD (1996) Neurobehavioral consequences of induced spreading depression following photothrombotic middle cerebral artery occlusion. Brain Res 15:273-282
3. Anyanwu EC (2007) Neurochemical changes in the aging process: implications in medication in the elderly. Scientific World J 7:1603-1610
4. Apfeld J, O'Connor G, McDonagh T, DiStefano PS, Curtis R (2004) The AMP-activated protein kinase AAK-2 links energy levels and insulin-like signals to lifespan in C. elegans. Genes Dev 18:3004-3009
5. Baquer NZ, Taha A, Kumar P, McLean P, Cowsik SM, Kale RK, Singh R, Sharma D (2009) A metabolic and functional overview of brain aging linked to neurological disorders. Biogerontology 10:377-413
6. Canto C, Gerhart-Hines Z, Feige JN, Lagouge M, Noriega L, Milne JC, Elliott PJ, Puigserver P, Auwerx J (2009) AMPK regulates energy expenditure by modulating NAD + metabolism and SIRT1 activity. Nature 458:1056-1060
7. Culmsee C, Monnig J, Kemp BE, Mattson MP (2001) AMP-activated protein kinase is highly expressed in neurons in the developing rat brain and promotes neuronal survival following glucose deprivation. J Mol Neurosci 17:45-58
8. Fulco M, Sartorelli V (2008) Comparing and contrasting the roles of AMPK and SIRT1 in metabolic tissues. Cell Cycle 7:3669-3679
9. Gonzales RA, Brown LM, Jones TW, Trent RD, Westbrook SL, Leslie SW (1991) N-methyl-d-aspartate mediated responses decrease with age in Fischer 344 rat brain. Neurobiol Aging 12:219-225
10. Grabowski M, Brundin P, Johansson BB (1993) Paw-reaching, sensorimotor, and rotational behavior after brain infarction in rats. Stroke 24:889-895
11. Hardie DG (2007) AMP-activated/SNF1 protein kinases: conserved guardians of cellular energy. Nat Rev Mol Cell Biol 8:774-785
12. Hardie DG, Hawley SA (2001) AMP-activated protein kinase: the energy charge hypothesis revisited. Bioessays 23:1112-1119
13. Hawley SA, Davison M, Woods A, Davies SP, Beri RK, Carling D, Hardie DG (1996) Characterization of the AMP-activated protein kinase kinase from rat liver and identification of threonine 172 as the major site at which it phosphorylates AMP-activated protein kinase. J Biol Chem 271:27879-27887
14. Howitz KT, Bitterman KJ, Cohen HY, Lamming DW, Lavu S, Wood JG, Zipkin RE, Chung P, Kisielewski A, Zhang LL, Scherer B, Sinclair DA (2003) Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature 425:191-196
15. Imai S (2007) Is Sirt1 a miracle bullet for longevity? Aging Cell 6:735-737
16. Jung JE, Lee J, Ha J, Kim SS, Cho YH, Baik HH, Kang I (2004) 5-Aminoimidazole-4-carboxamide-ribonucleoside enhances oxidative stress-induced apoptosis through activation of nuclear factor-kappaB in mouse Neuro 2a neuroblastoma cells. Neurosci Lett 354:197-200
17. Khaliulin I, Clarke SJ, Lin H, Parker J, Suleiman MS, Halestrap AP (2007) Temperature preconditioning of isolated rat hearts - a potent cardioprotective mechanism involving a reduction in oxidative stress and inhibition of the mitochondrial permeability transition pore. J Physiol 581:1147-1161
18. Kim EK, Miller I, Aja S, Landree LE, Pinn M, McFadden J, Kuhajda FP, Moran TH, Ronnett GV (2004) C75, a fatty acid synthase inhibitor, reduces food intake via hypothalamic AMP-activated protein kinase. J Biol Chem 279:19970-19976
19. Krieger DW, Yenari MA (2004) Therapeutic hypothermia for acute ischemic stroke: what do laboratory studies teach us? Stroke 35:1482-1489
20. Kuramoto N, Wilkins ME, Fairfax BP, Revilla-Sanchez R, Terunuma M, Tamaki K, Iemata M, Warren N, Couve A, Calver A, Horvath Z, Freeman K, Carling D, Huang L, Gonzales C, Cooper E, Smart TG, Pangalos MN, Moss SJ (2007) Phospho-dependent functional modulation of GABA(B) receptors by the metabolic sensor AMP-dependent protein kinase. Neuron 53:233-247
21. Lazzaro MA, Prabhakaran S (2008) Induced hypothermia in acute ischemic stroke. Expert Opin Investig Drugs 17:1161-1174
22. Li J, McCullough LD (2010) Effects of AMP-activated protein kinase in cerebral ischemia. J Cereb Blood Flow Metab 30:480-492
23. Li J, Zeng Z, Viollet B, Ronnett GV, McCullough LD (2007) Neuroprotective effects of adenosine monophosphate-activated protein kinase inhibition and gene deletion in stroke. Stroke 38:2992-2999
24. Li X, Blizzard KK, Zeng Z, DeVries AC, Hurn PD, McCullough LD (2004) Chronic behavioral testing after focal ischemia in the mouse: functional recovery and the effects of gender. Exp Neurol 187:94-104
25. Liu D, Gharavi R, Pitta M, Gleichmann M, Mattson MP (2009a) Nicotinamide prevents NAD + depletion and protects neurons against excitotoxicity and cerebral ischemia: NAD + consumption by SIRT1 may endanger energetically compromised neurons. Neuromolecular Med 11:28-42
26. Liu F, Yuan R, Benashski SE, McCullough LD (2009b) Changes in experimental stroke outcome across the life span. J Cereb Blood Flow Metab 29:792-802
27. Ljubicic V, Hood DA (2009) Diminished contraction-induced intracellular signaling towards mitochondrial biogenesis in aged skeletal muscle. Aging Cell 8:394-404
28. Love S (2003) Apoptosis and brain ischaemia. Prog Neuropsychopharmacol Biol Psychiatry 27:267-282
29. Lyden PD, Allgren RL, Ng K, Akins P, Meyer B, Al-Sanani F, Lutsep H, Dobak J, Matsubara BS, Zivin J (2005) Intravascular cooling in the treatment of stroke (ICTuS): early clinical experience. J Stroke Cerebrovasc Dis 14:107-114
30. McCullough LD, Zeng Z, Blizzard KK, Debchoudhury I, Hurn PD (2005a) Ischemic nitric oxide and poly (ADP-ribose) polymerase-1 in cerebral ischemia: male toxicity, female protection. J Cereb Blood Flow Metab 25:502-512
31. McCullough LD, Zeng Z, Li H, Landree LE, McFadden J, Ronnett GV (2005b) Pharmacological inhibition of AMP-activated protein kinase provides neuroprotection in stroke. J Biol Chem 280:20493-20502
32. Mulligan JD, Gonzalez AA, Kumar R, Davis AJ, Saupe KW (2005) Aging elevates basal adenosine monophosphate-activated protein kinase (AMPK) activity and eliminates hypoxic activation of AMPK in mouse liver. J Gerontol A Biol Sci Med Sci 60:21-27
33. Nakatsu Y, Kotake Y, Hino A, Ohta S (2008) Activation of AMP-activated protein kinase by tributyltin induces neuronal cell death. Toxicol Appl Pharmacol 230:358-363
34. Nemoto S, Fergusson MM, Finkel T (2004) Nutrient availability regulates SIRT1 through a forkhead-dependent pathway. Science 306:2105-2108
35. Osiewacz HD (2002) Genes, mitochondria and aging in filamentous fungi. Ageing Res Rev 1:425-442
36. Petersen KF, Befroy D, Dufour S, Dziura J, Ariyan C, Rothman DL, DiPietro L, Cline GW, Shulman GI (2003) Mitochondrial dysfunction in the elderly: possible role in insulin resistance. Science 300:1140-1142
37. Pillai VB, Sundaresan NR, Kim G, Gupta M, Rajamohan SB, Pillai JB, Samant S, Ravindra PV, Isbatan A, Gupta MP (2010) Exogenous NAD blocks cardiac hypertrophic response via activation of the SIRT3-LKB1-AMP-activated kinase pathway. J Biol Chem 285:3133-3144
38. Qiang W, Weiqiang K, Qing Z, Pengju Z, Yi L (2007) Aging impairs insulin-stimulated glucose uptake in rat skeletal muscle via suppressing AMPKalpha. Exp Mol Med 39:535-543
39. Raval AP, Lin HW, Dave KR, Defazio RA, Della Morte D, Kim EJ, Perez-Pinzon MA (2008) Resveratrol and ischemic preconditioning in the brain. Curr Med Chem 15:1545-1551
40. Reznick RM, Zong H, Li J, Morino K, Moore IK, Yu HJ, Liu ZX, Dong J, Mustard KJ, Hawley SA, Befroy D, Pypaert M, Hardie DG, Young LH, Shulman GI (2007) Aging-associated reductions in AMP-activated protein kinase activity and mitochondrial biogenesis. Cell Metab 5:151-156
41. Ronnett GV, Kim EK, Landree LE, Tu Y (2005) Fatty acid metabolism as a target for obesity treatment. Physiol Behav 85:25-35
42. Ronnett GV, Ramamurthy S, Kleman AM, Landree LE, Aja S (2009) AMPK in the brain: its roles in energy balance and neuroprotection. J Neurochem 109(Suppl 1):17-23
43. Rosamond W, Flegal K, Furie K, Go A, Greenlund K, Haase N, Hailpern SM, Ho M, Howard V, Kissela B, Kittner S, Lloyd-Jones D, McDermott M, Meigs J, Moy C, Nichol G, O'Donnell C, Roger V, Sorlie P, Steinberger J, Thom T, Wilson M, Hong Y (2008) Heart disease and stroke statistics - 2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 117:e25-e146
44. Shapira S, Sapir M, Wengier A, Grauer E, Kadar T (2002) Aging has a complex effect on a rat model of ischemic stroke. Brain Res 925:148-158
45. Suwa M, Nakano H, Radak Z, Kumagai S (2008) Endurance exercise increases the SIRT1 and peroxisome proliferator-activated receptor gamma coactivator-1alpha protein expressions in rat skeletal muscle. Metabolism 57:986-998
46. Tissenbaum HA, Guarente L (2002) Model organisms as a guide to mammalian aging. Dev Cell 2:9-19
47. Tota S, Awasthi H, Kamat PK, Nath C, Hanif K (2010) Protective effect of quercetin against intracerebral streptozotocin induced reduction in cerebral blood flow and impairment of memory in mice. Behav Brain Res 209:73-79
48. Turdi S, Fan X, Li J, Zhao J, Huff AF, Du M, Ren J (2010) AMP-activated protein kinase deficiency exacerbates aging-induced myocardial contractile dysfunction. Aging Cell 9:592-606
49. Vingtdeux V, Davies P, Dickson DW, Marambaud P (2010) AMPK is abnormally activated in tangle- and pre-tangle-bearing neurons in Alzheimer's disease and other tauopathies. Acta Neuropathol. doi: 10.1007/s00401-010-0759-x
50. Wang W, Yang X, Lopez de Silanes I, Carling D, Gorospe M (2003) Increased AMP:ATP ratio and AMP-activated protein kinase activity during cellular senescence linked to reduced HuR function. J Biol Chem 278:27016-27023
51. Weisova P, Davila D, Tuffy LP, Ward MW, Concannon CG, Prehn JH (2010) Role of AMP-activated protein kinase (AMPK) in cell survival and death responses in neurons. Antioxid Redox Signal. doi: 10.1089/ars.2010.3544
52. Wenk GL, Walker LC, Price DL, Cork LC (1991) Loss of NMDA, but not GABA-A, binding in the brains of aged rats and monkeys. Neurobiol Aging 12:93-98
53. Wood JG, Rogina B, Lavu S, Howitz K, Helfand SL, Tatar M, Sinclair D (2004) Sirtuin activators mimic caloric restriction and delay ageing in metazoans. Nature 430:686-689
54. Zhou G, Myers R, Li Y, Chen Y, Shen X, Fenyk-Melody J, Wu M, Ventre J, Doebber T, Fujii N, Musi N, Hirshman MF, Goodyear LJ, Moller DE (2001) Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest 108:1167-1174